Mucosan Pediátrico (Ambroxol Hydrochloride)

Ambroxol Hydrochloride acts as a mucolytic on the respiratory tract, improving mucus clearance in several common pediatric conditions.

• Acute respiratory tract infection cough: reduces mucus thickness and eases cough frequency in children.
• Bronchitis: enhances mucociliary clearance, helping relieve congestion and improve breathing.
• Upper respiratory tract infection: lowers mucus viscosity, supporting symptom relief and faster recovery.

• Ambroxol Hydrochloride stimulates the production of pulmonary surfactant and increases the activity of serine proteases in the airway epithelium, leading to a reduction in mucus viscosity. By enhancing ciliary beat frequency, it promotes mucociliary transport, facilitating the removal of secretions from the respiratory tract. The combined effect results in clearer airways and reduced cough. Additionally, ambroxol exhibits mild anti‑inflammatory properties that may further aid airway comfort.

Ambroxol Hydrochloride may cause a range of adverse reactions, varying from mild to rare serious events.

Common Side Effects

• Nausea: mild stomach upset that may occur after oral administration.
• Taste disturbance: a temporary bitter or salty taste in the mouth.
• Diarrhea: loose stools occurring during treatment.
• Skin rash: mild erythematous rash on the trunk or limbs.

Serious or Rare Side Effects

• Allergic reactions: hives, swelling, or anaphylaxis requiring immediate medical attention.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hepatic enzyme elevation: significant increase in liver transaminases indicating possible liver involvement.

When prescribing Ambroxol Hydrochloride, healthcare professionals should consider several precautionary measures to ensure safe use.

• Renal impairment: adjust dose in patients with reduced kidney function.
• Hepatic disease: use with caution in liver disorders and monitor liver function.
• Known hypersensitivity: avoid in individuals with documented allergy to ambroxol or similar compounds.
• Gastrointestinal upset: monitor for persistent nausea or diarrhea and provide supportive care.
• Young children: use under medical supervision in children under two years of age.
• Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Ambroxol Hydrochloride has a low interaction potential, but certain drug combinations require attention.

Major Interactions (Avoid)

• Other mucolytics: concurrent use with agents such as N‑acetylcysteine may increase gastrointestinal irritation.
• Hypersensitivity‑inducing drugs: combining with medications known to cause allergic reactions (e.g., penicillins) may raise the risk of severe hypersensitivity.

Moderate Interactions (Monitor Closely)

• Antacids: may reduce ambroxol absorption; separate administration by at least two hours.
• Anticoagulants (e.g., warfarin): monitor INR values as ambroxol could potentiate anticoagulant effect.
• Bronchodilators: no direct interaction, but clinical response should be observed when used together.